Relaxin Can Mediate Its Anti-Fibrotic Effects by Targeting the Myofibroblast NLRP3 Inflammasome at the Level of Caspase-1 by Anita A. Pinar, Alexander Yuferov, Tracey A. Gaspari, Chrishan S. Samuel, Chrishan S. Samuel

Connect to this object online.

Editorial: Novel Therapeutic Targets and Emerging Treatments for Fibrosis by Chrishan S. Samuel, Timothy D. Hewitson, Timothy D. Hewitson

Connect to this object online.

Serelaxin Elicits Bronchodilation and Enhances β-Adrenoceptor-mediated Airway Relaxation by Maggie Lam, Simon G Royce, Chantal Donovan, Maria Jelinic, Laura J Parry, Chrishan S Samuel, Jane Elizabeth Bourke

Connect to this object online.

THE ANTI-FIBROTIC ACTIONS OF RELAXIN ARE MEDIATED THROUGH A NO-sGC-cGMP-DEPENDENT PATHWAY IN RENAL MYOFIBROBLASTS IN VITRO AND ENHANCED BY THE NO DONOR, DIETHYLAMINE NONOATE by Chao eWang, Barbara Kathryn Kemp-Harper, Martina eKocan, Sheng Yu eAng, Tim David Hewitson, Chrishan S Samuel

Connect to this object online.

Epigenetic Modifications to H3K9 in Renal Tubulointerstitial Cells after Unilateral Ureteric Obstruction and TGF-β1 Stimulation by Timothy D. Hewitson, Timothy D. Hewitson, Stephen G. Holt, Stephen G. Holt, Sven-Jean Tan, Belinda Wigg, Chrishan S. Samuel, Edward R. Smith, Edward R. Smith

Connect to this object online.

Anti-fibrotic Potential of AT2 Receptor Agonists by Yan Wang, Mark Del Borgo, Huey W. Lee, Dhaniel Baraldi, Baydaa Hirmiz, Tracey A. Gaspari, Kate M. Denton, Marie-Isabel Aguilar, Chrishan S. Samuel, Robert E. Widdop

Connect to this object online.

Novel Therapeutic Targets and Emerging Treatments for Fibrosis by Timothy D. Hewitson

Other Authors: “…Chrishan S. Samuel…”
DOAB: download the publication
DOAB: description of the publication